CYRAMZA (ramucirumab)

**Product type:** Human Prescription Drug

**Active ingredient:** RAMUCIRUMAB

**Strength:** 10 mg/mL

**Dosage form:** Solution

**Route:** Intravenous

**Labeler:** Eli Lilly and Company

**Marketing category:** BLA (BLA125477)

**Pharmacologic class:** VEGFR2 Inhibitors [MoA], Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]